Ivermectin labelled ‘possible treatment’ 29 months into pandemic

Mike Campbell

September 8, 2022

Months after Health Canada claimed it’s “disinformation” to use ivermectin to treat COVID-19, the American health agency is considering the drug as a “possible treatment.”

Ivermectin labelled 'possible treatment' 29 months into pandemic
Ivermectin labelled ‘possible treatment’ 29 months into pandemic.

Under “COVID-19 Treatment Guidelines,” the National Health Institute’s (NIH) website lists ivermectin as “an antiparasitic drug that is being evaluated to treat COVID-19.”

The NIH’s current evaluation suggests ivermectin can be used to treat the novel coronavirus.

“Reports from in vitro studies suggest that ivermectin acts by inhibiting host importin alpha/beta-1 nuclear transport proteins, which are part of a key intracellular transport process,” the listing reads.

“Viruses hijack the process and enhance infection by suppressing the host’s antiviral response. In addition, ivermectin docking may interfere with SARS-CoV-2 spike protein attachment to the human cell membrane. Some studies of ivermectin have also reported potential anti-inflammatory properties, which have been postulated to be beneficial in people with COVID-19.”

The assessment explicitly recommends “against the use of ivermectin for the treatment of COVID-19, except in clinical trials.”

The most recent update to the NIH website is April 29, 2022. In the time since, a new peer-reviewed study involving almost 90,000 patients indicated that ivermectin significantly reduced the chances of hospitalization and death in COVID-infected individuals.

Ivermectin has been a controversial treatment for over two years, with health authorities on the government payroll censoring and shaming medical experts who argued it’s effective in treating COVID.

Canada’s state broadcaster CBC News ran a piece about COVID “disinformation” in which Health Canada stated there’s no evidence of the drug’s utility.

Canadian Heritage Minister Pablo Rodriquez — who is pushing for censorship of so-called “disinformation” through Bill C-11 — has alluded to censoring outlets that suggest ivermectin can treat COVID.

“We are having discussions internally because there’s no way that Canada Heritage will support any type of disinformation,” he said in March.

In May, the Missouri Legislature passed a bill preventing state licensing boards from punishing doctors who “lawfully” prescribe ivermectin or hydroxychloroquine to treat COVID.

“Unfortunately, because of the politicization of those two drugs, [doctors are] being targeted,” Sen. Rick Brattin said. “I wanted to protect them from that.”

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Canada’s 2022 excess deaths trajectory is on pace to shatter the total from 2021 – and obliterate that from 2020.

Mike Campbell

January 27, 2023

Trending News

Canada had more excess deaths in vaccine-coerced 2021 than in 2020 when the pandemic supposedly ravaged the country coast to coast — without vaccines.

Mike Campbell

January 26, 2023

Trending News

Alberta Premier Danielle Smith said Albertans would lose 25% of their economy if the federal government’s Just Transition proposal becomes law under a provincial NDP government.  

TCS Wire

January 17, 2023

Trending News

Over 53,000 Canadians have suffered an adverse effect from the Covid-19 vaccine, whereas just under 50,000 Canadians have died from the virus. 

Mike Campbell

January 17, 2023

Trending News

Alberta professor and Covid-19 vaccine influencer Tim Caulfield blocked a debate moderator on Twitter after she shared an open letter from vaccine critic Byram Bridle challenging Caulfield to a debate.

Mike Campbell

January 16, 2023

Trending News

The BBC aired an interview with a cardiologist attributing increased heart-related incidents to Covid-19 vaccines. 

Mike Campbell

January 13, 2023

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.